The purpose of the study was to determine the peculiarity of left ventricular remodeling among patients with hypertension developing acute myocardial infarction. Material and methods. The results of the study are based on the data of a comprehensive examination of 477 patients with coronary artery disease: 280 patients with STEMI (ST-segment elevation myocardial infarction), 91 patients with NSTEMI (non ST-segment elevation myocardial infarction) and the control group consisted of 76 patients with exertional angina (II and III functional class for 38 people). The examination of patients was carried out in the period from 2015 to January 2018 on the basis of the Regional Medical Center for Cardiovascular Diseases of the Zaporozhye Regional Council. All patients (n=477) were comparable in age, social status and gender. The proportion of patients with hypertension was comparable between the groups and amounted to 255 (91.1%) patients with STEMI, 86 (94.5%) with NSTEMI, and 71 (93.4%) patients with stable coronary artery disease. Results and discussion. The development of left ventricular hypertrophy is a long-term process in hypertensive patients. At first, there is a change in the geometry of the left ventricle, since during systole the ventricle tends to take a spherical shape. Further, dilatation of cavities, hypertrophy and an increase in the mass of the left ventricular myocardium, replacement of the myocardium with fibrous tissue develop. Whereas in patients with acute myocardial infarction, due to acute myocardial ischemia, thickening of the myocardial wall is associated with interstitial edema occurs rather quickly. These important factors make it difficult to compare different studies and to reliably identify patients with true left ventricular hypertrophy. Therefore, left ventricular myocardium mass index should be determined as early as possible in patients with hypertension after the development of acute myocardial infarction, in order to interpret the obtained data. Сonclusion. Ischemic heart disease is often associated with essential hypertension, more than 90% of patients with acute myocardial infarction developed essential hypertension. It was determined that eccentric and concentric left ventricular hypertrophy prevailed among those examined on the first day of hospitalization and was due to the presence of hypertension

Keywords: remodeling, left ventricle, acute myocardial infarction, hypertrophy

Full text: PDF (Ukr) 293K

1. Ruden' VV. Mediko-socіal'nі osoblivostі zahvoryuvanostі gіpertonіchnoyu hvoroboyu naselennya Ukraїni [Medical and social features of the incidence of hypertension in the population of Ukraine]. Ukraїna. Zdorov'ya nacії. 2020; 3(30): 84-91. [Ukrainian]
2. Kranenburg G, Spiering W, de Jong PA, Kappelle LJ, de Borst GJ, Cramer MJ, et al. Inter-arm systolic blood pressure differences, relations with future vascular events and mortality in patients with and without manifest vascular disease. International Journal of Cardiology. 2017; 244: 271-276.
3. https://doi.org/10.1016/j.ijcard.2017.06.044. PMid:28641891
4. Zhang H, Hu L, Wei X. Prognostic value of left ventricular hypertrophy in hypertensive patients: A meta-analysis of electrocardiographic studies. The Journal of Clinical Hypertension. 2020; 22(2): 254-260. https://doi.org/10.1111/jch.13795. PMid:31955500
5. Chen JS, Pei Y, Li CE, Li YN, Wang QY, Yu J. Comparative efficacy of different types of antihypertensive drugs in reversing left ventricular hypertrophy as determined with echocardiography in hypertensive patients: A network meta-analysis of randomized controlled trials. The Journal of Clinical Hypertension. 2020 Dec; 22(12): 2175-2183. https://doi.org/10.1111/jch.14047. PMid:33190366
6. Lazzeroni D, Rimoldi O, Camici PG. From left ventricular hypertrophy to dysfunction and failure. Circulation Journal. 2016; 80(3): 555-564. https://doi.org/10.1253/circj.CJ-16-0062. PMid:26853555
7. Stewart MH, Lavie CJ, Shah S, Englert J, Gilliland Y, Qamruddin S, et al. Prognostic implications of left ventricular hypertrophy. Progress in cardiovascular diseases. 2018; 61(5-6): 446-455. https://doi.org/10.1016/j.pcad.2018.11.002. PMid:30408469
8. Pedersen LR, Kristensen AMD, Petersen SS, Vaduganathan M, Bhatt DL, Juel J, et al. Prognostic implications of left ventricular hypertrophy diagnosed on electrocardiogram vs echocardiography. The Journal of Clinical Hypertension. 2020; 22(9): 1647-1658. https://doi.org/10.1111/jch.13991. PMid:32813895
9. Prastaro M, Pirozzi E, Gaibazzi N, Paolillo S, Santoro C, Savarese G, et al. Expert review on the prognostic role of echocardiography after acute myocardial infarction. Journal of the American Society of Echocardiography. 2017; 30(5): 431-443. https://doi.org/10.1016/j.echo.2017.01.020. PMid:28477781
10. Elgendy IY, Bavry AA, Gong Y, Handberg EM, Cooper-DeHoff RM, Pepine CJ. Long-term mortality in hypertensive patients with coronary artery disease: results from the US cohort of the International Verapamil (SR)/Trandolapril Study. Hypertension. 2016; 68(5): 1110-1114. https://doi.org/10.1161/HYPERTENSIONAHA.116.07854. PMid:27620390 PMCid:PMC5063713
11. Mahtta D, Elgendy IY, Pepine CJ. Optimal medical treatment of hypertension in patients with coronary artery disease. Expert review of cardiovascular therapy. 2018; 16(11): 815-823. https://doi.org/10.1080/14779072.2018.1534069. PMid:30295548 PMCid:PMC6380682
12. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. European heart journal. 2012; 33(20): 2551-2567. https://doi.org/10.1093/eurheartj/ehs184. PMid:22922414
13. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction. European heart journal. 2018; 40(3): 237-269. https://doi.org/10.1093/eurheartj/ehy462
14. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. European Heart Journal-Cardiovascular Imaging. 2015; 16(3): 233-271. https://doi.org/10.1093/ehjci/jev014. PMid:25712077
15. Marwick TH, Gillebert TC, Aurigemma G, Chirinos J, Derumeaux G, Galderisi M, et al. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). European Heart Journal-Cardiovascular Imaging. 2015; 16(6): 577-605. https://doi.org/10.1016/j.echo.2015.05.002
16. Stanton T, Dunn FG. Hypertension, left ventricular hypertrophy, and myocardial ischemia. Medical Clinics. 2017; 101(1): 29-41. https://doi.org/10.1016/j.mcna.2016.08.003. PMid:27884233
17. Yildiz M, Oktay AA, Stewart MH, Milani RV, Ventura HO, Lavie CJ. Left ventricular hypertrophy and hypertension. Progress in cardiovascular diseases. 2020; 63(1): 10-21. https://doi.org/10.1016/j.pcad.2019.11.009. PMid:31759953
18. Stiermaier T, Pöss J, Eitel C, de Waha S, Fuernau G, Desch S, et al. Impact of left ventricular hypertrophy on myocardial injury in patients with ST-segment elevation myocardial infarction. Clinical Research in Cardiology. 2018; 107(11): 1013-1020. https://doi.org/10.1007/s00392-018-1273-8. PMid:29766285
19. Nepper-Christensen L, Lønborg J, Ahtarovski KA, Høfsten DE, Kyhl K, Ghotbi AA, et al. Left ventricular hypertrophy is associated with increased infarct size and decreased myocardial salvage in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Journal of the American Heart Association. 2017; 6(1): e004823. https://doi.org/10.1161/JAHA.116.004823. PMid:28069574 PMCid:PMC5523642